1. Gallium(III)- and Thallium(III)-Encapsulated Polyoxopalladates: Synthesis, Structure, Multinuclear NMR, and Biological Activity Studies.
- Author
-
Ma T, Ma X, Lin Z, Zhang J, Yang P, Csupász T, Tóth I, Misirlic-Dencic S, Isakovic AM, Lembo D, Donalisio M, and Kortz U
- Subjects
- Humans, Nuclear Magnetic Resonance, Biomolecular, Magnetic Resonance Spectroscopy, Magnetic Resonance Imaging, Thallium chemistry, Gallium pharmacology, Gallium chemistry
- Abstract
Three gallium(III)- and thallium(III)-containing polyoxopalladates (POPs) have been synthesized and structurally characterized in the solid state and in solution, namely, the phosphate-capped 12-palladate nanocubes [XPd
12 O8 (PO4 )8 ]13- (X = GaIII , GaPd12 P8 ; X = TlIII , TlPd12 P8 ) and the 23-palladate double-cube [Tl2 III Pd23 P14 O70 (OH)2 ]20- ( Tl2 Pd23 P14 ). The cuboid POPs, GaPd12 P8 and TlPd12 P8 , are solution stable as verified by the respective31 P,71 Ga, and205 Tl nuclear magnetic resonance (NMR) spectra. Of prime interest, the spin-spin coupling schemes allowed for an intimate study of the solution behavior of the TlIII -containing POPs via a combination of31 P and205 Tl NMR, including the stoichiometry of the major fragments of Tl2 Pd23 P14 . Moreover, biological studies demonstrated the antitumor and antiviral activity of GaPd12 P8 and TlPd12 P8 , which were validated to be as efficient as cis -platinum against human melanoma and acute promyelocytic leukemia cells. Furthermore, GaPd12 P8 and TlPd12 P8 exerted inhibitory activity against two herpetic viruses, HSV-2 and HCMV, in a dose-response manner.- Published
- 2023
- Full Text
- View/download PDF